Q&A with FDA Podcast: CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito
Starts On:
Thu, 1/18/24: 12:00 AM EST
Ends On:
Sun, 1/17/27: 12:00 AM EST
Type:
Enduring Material
Credits:
0.5
Description:
This enduring material focuses on the significance of CURE ID, an internet-based repository, that allows the global community to report novel uses of existing drugs for difficult-to-treat diseases through a website, a smartphone, or other mobile device. This activity describes the purpose of CURE ID along with potential improvements and future expansion of disease areas within the CURE ID app.
Objectives:
- Summarize the purpose of CURE ID and its relation in enhancing the FDA's role in supporting real-world data.
- Discuss the significance and latest developments of CURE ID in providing accessibility to clinical experience of repurposing drugs when there is an immediate need of new treatments in the absence of drug development.
- Describe the objective of CURE ID in potentially streamlining the transition of treatment discoveries into clinical trials, offering valuable clinical data to refine trial hypotheses and strategic designs.
- Explain the uses of the tool within specialized patient populations such as pregnant people and neonates for whom treatment data is often limited.
Additional Information:
Review the Activity Announcement for additional details: Announcement Form